Organization of polish and german health care systems in the context of drug policy
DOI:
https://doi.org/10.12775/MBS.2015.002Keywords
Polish health system, German health system, organization and management in healthcareAbstract
Healthcare system in Germany is considered as one of the most effective systems all over Europe. Even in the face the ageing population, German healthcare is placed first in terms of the saturation in advanced medical technologies and access to medicinal products. Differences between the functioning of healthcare systems in Germany and other countries, such as Poland, are reflected by many epidemiological indicators.
The main purpose of that article is to present the differences in functioning the Polish and German systems, bearing in mind drug policy and regulations. In the article, there are presented some organizational and financing principles concerning healthcare systems in these countries as well as the healthcare expenditures structures.References
OECD data, http://www.oecd.org/health/, [access: 12.09.2014].
European Cancer Observatory data, http://eco.iarc.fr/, [access: 12.09.2014].
Ferlay J, et al. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010 Mar;46(4):765-81.
CDC data, http://www.cdc.gov/nchs/data/databriefs/ db23.pdf, [access: 12.09.2014].
Outline of the health care system - POLAND 2012 National Health Fund, European Observatory on Health Systems and Policies, Warsaw 2012.
The Act of 23 January 2003. On general insurance in the National Health Fund, OJ 2003 No. 45, item. 391.
Sobczak A, Polish health care system rating, akademia.nfz.gov.pl, [access: 12.09.2014].
The Polish population health and its determinants, Wojtyniak G Goryński P Moskalewicz B (ed.), National Institute of Public Health - National Institute of Hygiene, Warsaw 2012.
Regulation of the European Parliament and Council Regulation (EC) No 883/2004 of 29 April 2004 on the coordination of social security systems (L 166 of 30 April 2004 as amended.).
Central Statistical Office, National Health Account for the year 2011.
The health care benefits financed from public funds, Tyszko R (ed.), National Health Fund, Warsaw 2012.
Council Directive of 21 December 1988. Relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion in the scope of national health insurance systems (89/105/EEC).
The Act of 12 May 2011. For reimbursement of medicines, foodstuffs intended for particular nutritional and medical devices, OJ 2011 No. 122, item. 696, as amended.
Financing of the German Healthcare System, Office of the Senate, Office of Research and Documentation, Department of Analysis and Thematic Studies, Warsaw 2010.
The report summarizing the assessment of substantive projects with the health sector in order to select a pilot project for implementation in the form of a public-private platform Public-Private Partnership, Warsaw 2013.
http://www.arbeitsgemeinschaft-private-krankenversicherung.org/pkv-versicherungspflichtgrenze-fuer-2014-auf-53-550-euro-erhoeht/ [access: 05.09.2014].
Hibner E, management in the health system, Lodz 2003.
http://www.oecd.org/els/health-systems/Briefing-Note-GERMANY-2014.pdf [access: 09.05.2014].
The world health report 2000 - Health systems: Improving performance, WHO, Geneva. 2000.
http://www.rynekzdrowia.pl/Rynek-Zdrowia/Niemcy-i-Wlochy-dwa-rozne-modele-refundacji-lekow,51647.html [access: 05.09.2014].
http://www.nfz-szczecin.pl/leki_w_panstwach_ueefta.htm [access: 05.09.2014].
Downloads
Published
How to Cite
Issue
Section
Stats
Number of views and downloads: 364
Number of citations: 0
